Pfizer bags approval for Neupogen biosimilar
admin 23rd July 2018 Uncategorised 0Pfizer’s Neupogen biosimilar Nivestym has been approved by the US Food and Drug Administration and is expected to hit the market at a “significant discount” to its reference drug.
More: Pfizer bags approval for Neupogen biosimilar
Source: News